The Solid Tumor v2 Panel is a robust 48-gene assay that simultaneously tests for key mutations present in solid tumors, including NSCLC, colorectal, melanoma, endometrial, pancreatic, GIST, bladder, thyroid, and gliomas. Additionally, genes with potential importance in immuno-oncology such as POLD1 and POLE are analyzed. The library preparation for this panel can be automated using the Beckman Coulter Biomek NGeniuS Next Generation Library Prep System. The panel uses proprietary Stem-Loop Inhibition Mediated amplification (SLIMamp®) technology, a tiled amplicon-based library prep chemistry, designed by AI-empowered VersaTile™ Primer Design tool, for efficient single-tube target enrichment.
| AKT1 | CYSLTR2 | FBXW7 | GNAS | KEAP1 | NTRK1 | PTEN * | SMAD4 |
| ALK | DDR2 | FGFR1 | H3F3A (H3-3A) | KIT | PDGFRA | PTPN11 | SRSF2 |
| ARAF | EGFR | FGFR2 | HIST1H3B (H3C2) | KRAS | PIK3CA | RAC1 | STK11 |
| BRAF | EIF1AX | FGFR3 | HRAS | MAP2K1 | PLCB4 | RAF1 | TERT |
| CDKN2A | ERBB2 | GNA11 | IDH1 | MET | POLD1 | RET | TP53 |
| CTNNB1 | ERBB4 | GNAQ | IDH2 | NRAS | POLE | SF3B1 | TSHR |
Genes marked in green indicate full CDS coverage * indicates full CDS with exception of exon 9, chr10: 89725157-89725229
Maintain control of samples and results with single-tube, tiled amplification that can be performed in-house by any NGS lab.
Achieve variant detection as low as 1% VAF† without UIDs ‡ even with limited DNA input or poor sample quality.
Improve lab efficiency and reduce “no calls”, repeat testing, and difficult interpretation decisions
| Parameter | Description / Value |
|---|---|
| Enrichment chemistry | Multiplex PCR using tiled amplicons |
| Number of genes / amplicons | 48 / 246 |
| Number of targets | Full CDS coverage of 3 genes; hotspots in 45 additional genes; 25.2kb total size. |
| Variant types | SNVs, small and medium indels. |
| Average amplicon size | 154 bp |
| Recommended DNA input range | 20ng to 80ng |
| Sample types | DNA from tissue, blood, or FFPE |
| Mapping rate | 98.0% |
| % on-target aligned reads | 98.0% |
| Coverage uniformity (% targets with >0.2X mean coverage) | 98.0% |
| Recommended Reads Per Sample | ~2 million paired-end reads |
*Mapping rate, % of on-target aligned reads, and coverage uniformity metrics are based on internal testing performed using reference standard materials.